MedPath

Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers

Terminated
Conditions
Colonic Diseases
Colorectal Cancer
Colorectal Neoplasms
Digestive System Diseases
Interventions
Device: Stool Sample Collection Kit
Registration Number
NCT02503631
Lead Sponsor
Exact Sciences Corporation
Brief Summary

The primary objective of this study is to obtain de-identified, clinically characterized, stool and plasma specimens for use in assessing new markers for the detection of neoplasms of the digestive tract.

Detailed Description

This is a multi-site, prospective sample collection study. Subjects will be men and women, 40-90 years of age, inclusive, each with a colonoscopic biopsy-based diagnosis of CRC and/or a pre-malignant colorectal lesion with large enough residual lesion to require subsequent surgical excision or complex colonoscopic polypectomy.

One stool sample from approximately 300 subjects will be collected in this study. A blood sample will also be collected from subjects.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
397
Inclusion Criteria
  • Subject is male or female, 40-90 years of age, inclusive.
  • Subject has a diagnosis of CRC, at any stage, confirmed with a tissue biopsy or colorectal polyp/adenoma/mass that is equal or larger than 1 cm in pre-enrollment colonoscopy with residual lesion in the colon of sufficient size to require additional surgical excision or complex colonoscopic polypectomy.
  • Subject understands the study procedures and is able to provided informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigator.
Exclusion Criteria
  • Subject has actively bleeding hemorrhoids (blood on toilet paper or bright red blood clots in the toilet bowel during bowel movement).
  • Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Colorectal cancer patientsStool Sample Collection KitSubjects will be men and women, 40-90 years of age, inclusive, each with a colonoscopic biopsy-based diagnosis of colorectal cancer (CRC) and/or a pre-malignant colorectal lesion with large enough residual lesion to require subsequent surgical excision or complex colonoscopic polypectomy.
Primary Outcome Measures
NameTimeMethod
To provide stool and blood specimens to assess new markers for the detection of CRC33 months
Secondary Outcome Measures
NameTimeMethod
To provide stool and blood specimens for use as controls when assessing new markers for the detection of neoplasms in other locations within the digestive tract (esophagus, stomach, pancreas, etc.)33 months
To provide quality control material for use in assessing performance of developed assays33 months
To provide stool and blood specimens for a biorepository for future cancer-related diagnostic test development33 months

Trial Locations

Locations (22)

Louisiana Research Center, LLC

🇺🇸

Shreveport, Louisiana, United States

DBA Boone Hospital Center

🇺🇸

Columbia, Missouri, United States

Chevy Chase Clinical Research

🇺🇸

Chevy Chase, Maryland, United States

John D. Homan, MD

🇺🇸

Newport Beach, California, United States

Asheville Gastroenterology Associates, PA

🇺🇸

Asheville, North Carolina, United States

New Orleans Research Institute

🇺🇸

Metairie, Louisiana, United States

Sundance Clinical Research, LLC

🇺🇸

Saint Louis, Missouri, United States

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

Colon and Rectal Surgery Associates

🇺🇸

Metairie, Louisiana, United States

Commonwealth Clinical Studies

🇺🇸

Brockton, Massachusetts, United States

Medical Research Center of Connecticut

🇺🇸

Hamden, Connecticut, United States

Gulf Coast Research Group, LLC

🇺🇸

Holiday, Florida, United States

Radiant Research, Inc.

🇺🇸

Anderson, South Carolina, United States

Cumberland Research Associates, LLC

🇺🇸

Fayetteville, North Carolina, United States

Main Line Gastroenterology Associates

🇺🇸

Malvern, Pennsylvania, United States

Forzani & MacPhali Colon Cancer Screening Centre

🇨🇦

Calgary, Alberta, Canada

Gastro One

🇺🇸

Germantown, Tennessee, United States

Blue Ridge Medical Researcj

🇺🇸

Lynchburg, Virginia, United States

Digestive and Liver Disease Specialists

🇺🇸

Norfolk, Virginia, United States

Endoscopic Research, Inc.

🇺🇸

Orlando, Florida, United States

Northwest Gastroenterology Clinic, LLC

🇺🇸

Portland, Oregon, United States

Quality Clinical Research, Inc.

🇺🇸

Omaha, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath